The natural compound forskolin synergizes with dexamethasone to induce cell death in myeloma cells via BIM
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep13001.pdf
Reference52 articles.
1. Parkin, D. M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74–108 (2005).
2. Laubach, J., Richardson, P. & Anderson, K. Multiple myeloma. Annu. Rev. Med. 62, 249–264 (2011).
3. Rajkumar, S. V. Multiple myeloma: 2013 update on diagnosis, risk-stratification and management. Am. J. Hematol. 88, 226–235 (2013).
4. Palumbo, A., Mateos, M. V., Bringhen, S. & San Miguel, J. F. Practical management of adverse events in multiple myeloma: can therapy be attenuated in older patients? Blood Rev. 25, 181–191 (2011).
5. Mateos, M. V. Management of treatment-related adverse events in patients with multiple myeloma. Cancer Treat. Rev. 36 Suppl 2, S24–S32 (2010).
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Forskolin affects proliferation, migration and Paclitaxel-mediated cytotoxicity in non-small-cell lung cancer cell lines via adenylyl cyclase/cAMP axis;European Journal of Cell Biology;2023-06
2. cAMP Agonist Forskolin Disrupts Mitochondrial Metabolism and Induces Senescence in Human Mesenchymal Cells;Stem Cells and Development;2023-02-01
3. Protein Kinase A–Mediated Effects of Protein Kinase C Partial Agonist 5-(Hydroxymethyl)Isophthalate 1a3 in Colorectal Cancer Cells;Journal of Pharmacology and Experimental Therapeutics;2021-10-25
4. Cdc25C/cdc2/cyclin B, raf/MEK/ERK and PERK/eIF2α/CHOP pathways are involved in forskolin-induced growth inhibition of MM.1S cells by G2/M arrest and mitochondrion-dependent apoptosis;Cell Cycle;2021-10-04
5. Epithelial-to-Mesenchymal Transition Is Not a Major Modulating Factor in the Cytotoxic Response to Natural Products in Cancer Cell Lines;Molecules;2021-09-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3